Health Canada drug identification number

DIN 02564327 — REDEMPLO 25 MG

REDEMPLO is a solution of Plozasiran marketed by ARROWHEAD PHARMACEUTICALS, INC.. The full Plozasiran monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02564327
Brand name
REDEMPLO
Active ingredient
Plozasiran
Strength
25 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
ARROWHEAD PHARMACEUTICALS, INC.
Health Canada status
MARKETED
Drug class
Lipid-modifying agent (APOC3-directed small interfering RNA)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.